These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 28950235)

  • 1. A physicochemical descriptor based method for effective and rapid screening of dual inhibitors against BACE-1 and GSK-3β as targets for Alzheimer's disease.
    Kumar A; Srivastava G; Sharma A
    Comput Biol Chem; 2017 Dec; 71():1-9. PubMed ID: 28950235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of naphthofuran moiety as potential dual inhibitor against BACE-1 and GSK-3β: molecular dynamics simulations, binding energy, and network analysis to identify first-in-class dual inhibitors against Alzheimer's disease.
    Kumar A; Srivastava G; Srivastava S; Verma S; Negi AS; Sharma A
    J Mol Model; 2017 Aug; 23(8):239. PubMed ID: 28741112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Docking, molecular dynamics, binding energy-MM-PBSA studies of naphthofuran derivatives to identify potential dual inhibitors against BACE-1 and GSK-3β.
    Kumar A; Srivastava G; Negi AS; Sharma A
    J Biomol Struct Dyn; 2019 Feb; 37(2):275-290. PubMed ID: 29310523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual BACE-1/GSK-3β Inhibitors to Combat Alzheimer's Disease: A Focused Review.
    Rampa A; Gobbi S; Concetta Di Martino RM; Belluti F; Bisi A
    Curr Top Med Chem; 2017; 17(31):3361-3369. PubMed ID: 29332582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and Application of a Virtual Screening Protocol for the Identification of Multitarget Fragments.
    Bottegoni G; Veronesi M; Bisignano P; Kacker P; Favia AD; Cavalli A
    ChemMedChem; 2016 Jun; 11(12):1259-63. PubMed ID: 26663255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Versatility of the Curcumin Scaffold: Discovery of Potent and Balanced Dual BACE-1 and GSK-3β Inhibitors.
    Di Martino RM; De Simone A; Andrisano V; Bisignano P; Bisi A; Gobbi S; Rampa A; Fato R; Bergamini C; Perez DI; Martinez A; Bottegoni G; Cavalli A; Belluti F
    J Med Chem; 2016 Jan; 59(2):531-44. PubMed ID: 26696252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rational Design of Dual Inhibitors for Alzheimer's Disease: Insights from Computational Screening of BACE1 and GSK-3β.
    Sai Varshini M; Reddy RA; Krishnamurthy PT; Selvaraj D
    Curr Comput Aided Drug Des; 2024; 20(6):998-1012. PubMed ID: 37921183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multitarget drug discovery for Alzheimer's disease: triazinones as BACE-1 and GSK-3β inhibitors.
    Prati F; De Simone A; Bisignano P; Armirotti A; Summa M; Pizzirani D; Scarpelli R; Perez DI; Andrisano V; Perez-Castillo A; Monti B; Massenzio F; Polito L; Racchi M; Favia AD; Bottegoni G; Martinez A; Bolognesi ML; Cavalli A
    Angew Chem Int Ed Engl; 2015 Jan; 54(5):1578-82. PubMed ID: 25504761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3,4-Dihydro-1,3,5-triazin-2(1H)-ones as the First Dual BACE-1/GSK-3β Fragment Hits against Alzheimer's Disease.
    Prati F; De Simone A; Armirotti A; Summa M; Pizzirani D; Scarpelli R; Bertozzi SM; Perez DI; Andrisano V; Perez-Castillo A; Monti B; Massenzio F; Polito L; Racchi M; Sabatino P; Bottegoni G; Martinez A; Cavalli A; Bolognesi ML
    ACS Chem Neurosci; 2015 Oct; 6(10):1665-82. PubMed ID: 26171616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent BACE-1 inhibitor design using pharmacophore modeling, in silico screening and molecular docking studies.
    John S; Thangapandian S; Sakkiah S; Lee KW
    BMC Bioinformatics; 2011 Feb; 12 Suppl 1(Suppl 1):S28. PubMed ID: 21342558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptor-based pharmacophore modeling, virtual screening, and molecular docking studies for the discovery of novel GSK-3β inhibitors.
    El Kerdawy AM; Osman AA; Zaater MA
    J Mol Model; 2019 May; 25(6):171. PubMed ID: 31129879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Navigating the Chemical Space of Multitarget-Directed Ligands: From Hybrids to Fragments in Alzheimer's Disease.
    Prati F; Cavalli A; Bolognesi ML
    Molecules; 2016 Apr; 21(4):466. PubMed ID: 27070562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perspectives for New and More Efficient Multifunctional Ligands for Alzheimer's Disease Therapy.
    Zagórska A; Jaromin A
    Molecules; 2020 Jul; 25(15):. PubMed ID: 32717806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential of natural product vs neurodegenerative disorders: In silico study of artoflavanocoumarin as BACE-1 inhibitor.
    Razzaghi-Asl N; Karimi A; Ebadi A
    Comput Biol Chem; 2018 Dec; 77():307-317. PubMed ID: 30445338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual-target compounds for Alzheimer's disease: Natural and synthetic AChE and BACE-1 dual-inhibitors and their structure-activity relationship (SAR).
    Ferreira JPS; Albuquerque HMT; Cardoso SM; Silva AMS; Silva VLM
    Eur J Med Chem; 2021 Oct; 221():113492. PubMed ID: 33984802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BACE inhibitors as potential therapeutics for Alzheimer's disease.
    Evin G; Kenche VB
    Recent Pat CNS Drug Discov; 2007 Nov; 2(3):188-99. PubMed ID: 18221231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational Investigation of Novel Compounds as Dual Inhibitors of AChE and GSK-3β for the Treatment of Alzheimer's Disease.
    Londhe SG; Shenoy M; Kini SG; Walhekar V; Kumar D
    Curr Top Med Chem; 2024; 24(19):1738-1753. PubMed ID: 38859777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of Potential Lead Compound from
    Youn K; Jun M
    Int J Mol Sci; 2024 Sep; 25(19):. PubMed ID: 39408835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and biological evaluation of harmine derivatives as potent GSK-3β/DYRK1A dual inhibitors for the treatment of Alzheimer's disease.
    Liu W; Liu X; Tian L; Gao Y; Liu W; Chen H; Jiang X; Xu Z; Ding H; Zhao Q
    Eur J Med Chem; 2021 Oct; 222():113554. PubMed ID: 34098466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Semi-synthetic isoflavones as BACE-1 inhibitors against Alzheimer's disease.
    Ribaudo G; Coghi P; Zanforlin E; Law BYK; Wu YYJ; Han Y; Qiu AC; Qu YQ; Zagotto G; Wong VKW
    Bioorg Chem; 2019 Jun; 87():474-483. PubMed ID: 30927588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.